EXPRESSION AND INFLUENCE OF MARTRIX METALLOPROTEINASE-9 (MMP-9)/TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN DIABETIC FOOT ULCERS (DFUS)

被引:0
|
作者
Li, G. [1 ]
Zou, X. [2 ]
Zhang, J. [1 ]
Zhu, Y. [1 ]
Jin, S. [2 ]
Li, B. [2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Hosp, Wuhan 430074, Hubei, Peoples R China
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:A16 / A16
页数:1
相关论文
共 50 条
  • [1] Expression and Influence of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers
    Li, Gongchi
    Zou, Xinhua
    Zhu, Youpeng
    Jing, Zhang
    Zhou, Lijun
    Wang, Dan
    Li, Binghui
    Chen, Zhenbing
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2017, 16 (01): : 6 - 13
  • [2] Engineering Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Variants with Improved Binding Selectivity toward Matrix Metalloproteinase-9 (MMP-9) as potential protein therapeutics
    Shoari, Alireza
    Hockla, Alexandra
    Coban, Matt
    Radisky, Evette
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S636 - S637
  • [3] Infiltrative capacity of T leukemia cell lines: A distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1)
    Anna Ivanoff
    Jyrki Ivanoff
    Kjell Hultenby
    Karl-Gösta Sundqvist
    Clinical & Experimental Metastasis, 1999, 17 : 695 - 711
  • [4] Infiltrative capacity of T leukemia cell lines: A distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1)
    Ivanoff, A
    Ivanoff, J
    Hultenby, K
    Sundqvist, KG
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (08) : 695 - 711
  • [5] Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-9 (TIMP-1) are elevated in patients with acute coronary syndromes
    Bei, E
    Manginas, A
    Degiannis, D
    Chaidaroglou, A
    Pilatis, N
    Koniavitou, E
    Cokkinos, DV
    EUROPEAN HEART JOURNAL, 2003, 24 : 432 - 432
  • [6] EXPRESSION OF MATRIX METALLOPROTEINASE-9 (MMP-9) AND TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE (TIMP-1) IN TISSUES WITH A DIAGNOSIS OF CHILDHOOD LYMPHOMA
    Bozkurt, Ceyhun
    Ertem, Ulya
    Oksal, Aysegul
    Sahin, Guerses
    Yueksek, Nazmiye
    Birgen, Dilek
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2008, 25 (07) : 621 - 629
  • [7] Insulin suppresses Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase-9 (MMP-9).
    Bandyopadhyay, A
    Aljada, A
    Mohanty, P
    Ghanim, H
    Syed, T
    Dandona, P
    DIABETOLOGIA, 2003, 46 : A365 - A365
  • [8] Insulin suppresses vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9)
    Dandora, P
    Aljada, A
    Mohanty, P
    Ghanim, H
    Syed, T
    Bandyopadhyay, A
    DIABETES, 2003, 52 : A200 - A200
  • [9] Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) as blood biomarkers of Alzheimer's disease
    Basic, J.
    Milosevic, V.
    Djordjevic, B.
    Stojiljkovic, V.
    Malobabic, M.
    Stoimenov, T. Jevtovic
    Stojanovic, I.
    FEBS OPEN BIO, 2022, 12 : 125 - 126
  • [10] Study of the level of sputum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor metalloproteinase-1 (TIMP-1) in COPD patients
    Esa, Sherif A.
    Rawy, Abeer M.
    El-Behissy, Mona M.
    Kamel, Mohamed H.
    El-Hwaitty, Hany Mohiy Mohamed Mustafa
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2014, 63 (04): : 870 - 876